fluoxetine and D-fructopyranose

fluoxetine has been researched along with D-fructopyranose in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (61.54)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devarajan, S; Dursun, SM1
Sanders, TA; Taylor, D; Werneke, U1
Li, Z; Maggard, M; Maglione, M; Mojica, WA; Morton, SC; Shekelle, PG; Shugarman, L; Solomon, V; Suttorp, M; Tu, W1
Cheng, JT; Chung, HH; Hsiao, SH; Tong, YC1
Almeida, MQ; Carvalho, DF; Cercato, C; Halpern, A; Mancini, MC1
Al-Zaman, Y; Aylwin, S1
Ciccocioppo, R; Cifani, C; Massi, M; Melotto, S; Polidori, C1
Ciccocioppo, R; Cifani, C; Di Francesco, C; Massi, M; Melotto, S; Righetti, C; Tessari, M; Zanoncelli, A1
Czyzyk, TA; Sahr, AE; Statnick, MA1
Kardeh, E; Mowla, A1
Barros, S; de Carvalho, J1
Kachowski, L; Over, DR; Qiu, K1
Baltasar-Tello, I; Escudero-Sánchez, AB; Guisado-Macías, JA; Méndez-Sánchez, F; Vaz-Leal, FJ; Zamora-Rodríguez, FJ1

Reviews

5 review(s) available for fluoxetine and D-fructopyranose

ArticleYear
Options for pharmacological management of obesity in patients treated with atypical antipsychotics.
    International clinical psychopharmacology, 2002, Volume: 17, Issue:4

    Topics: Amantadine; Antipsychotic Agents; Cimetidine; Cyclobutanes; Fluoxetine; Fructose; Humans; Lactones; Metformin; Nizatidine; Obesity; Orlistat; Topiramate; Weight Gain

2002
Pharmacological and surgical treatment of obesity.
    Evidence report/technology assessment (Summary), 2004, Issue:103

    Topics: Adult; Appetite Depressants; Bupropion; Cyclobutanes; Diethylpropion; Fluoxetine; Fructose; Gastric Bypass; Gastroplasty; Humans; Lactones; Lipase; Obesity; Orlistat; Phentermine; Topiramate

2004
[Therapeutical approach of obesity in Prader-Willi Syndrome].
    Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:6

    Topics: Adolescent; Anti-Obesity Agents; Bariatric Surgery; Child; Child, Preschool; Female; Fluoxetine; Fructose; Humans; Infant; Infant, Newborn; Male; Mazindol; Obesity; Prader-Willi Syndrome; Selective Serotonin Reuptake Inhibitors; Topiramate

2007
Emerging concepts in the medical and surgical treatment of obesity.
    Frontiers of hormone research, 2008, Volume: 36

    Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide

2008
Pathological gambling and primary antiphospholipid (Hughes) syndrome: a unique neuropsychiatric association.
    Lupus, 2011, Volume: 20, Issue:10

    Topics: Antidepressive Agents; Antiphospholipid Syndrome; Antipsychotic Agents; Clomipramine; Clozapine; Fluoxetine; Fructose; Gambling; Humans; Male; Middle Aged; Topiramate

2011

Trials

1 trial(s) available for fluoxetine and D-fructopyranose

ArticleYear
Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jun-01, Volume: 35, Issue:4

    Topics: Adult; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Fructose; Humans; Male; Neuroprotective Agents; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate

2011

Other Studies

7 other study(ies) available for fluoxetine and D-fructopyranose

ArticleYear
Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action?
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2001, Volume: 46, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Appetite; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fructose; Humans; Neuroprotective Agents; Obesity; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Topiramate; Weight Loss

2001
Chronic fluoxetine administration desensitizes the hyperglycemia but not the anorexia induced by serotonin in rats receiving fructose-enriched chow.
    Neuroscience letters, 2006, Aug-14, Volume: 404, Issue:1-2

    Topics: Animal Feed; Animals; Anorexia; Body Weight; Energy Intake; Feeding Behavior; Fluoxetine; Fructose; Hyperglycemia; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin

2006
A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam.
    Psychopharmacology, 2009, Volume: 204, Issue:1

    Topics: Animals; Appetite Depressants; Behavior, Animal; Bulimia; Cyclobutanes; Disease Models, Animal; Eating; Feeding Behavior; Female; Fluoxetine; Food Deprivation; Fructose; Midazolam; Rats; Rats, Sprague-Dawley; Stress, Psychological; Topiramate

2009
Pre-exposure to environmental cues predictive of food availability elicits hypothalamic-pituitary-adrenal axis activation and increases operant responding for food in female rats.
    Addiction biology, 2009, Volume: 14, Issue:4

    Topics: Adrenocorticotropic Hormone; Animals; Anti-Obesity Agents; Appetite Depressants; Cannabinoids; Conditioning, Operant; Corticosterone; Cues; Cyclobutanes; Environment; Feeding Behavior; Female; Fluoxetine; Fructose; Humans; Hypothalamo-Hypophyseal System; Motivation; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rats; Reproducibility of Results; Rimonabant; Selective Serotonin Reuptake Inhibitors; Topiramate

2009
A model of binge-like eating behavior in mice that does not require food deprivation or stress.
    Obesity (Silver Spring, Md.), 2010, Volume: 18, Issue:9

    Topics: Adiposity; Animals; Anti-Obesity Agents; Baclofen; Behavior, Animal; Binge-Eating Disorder; Body Weight; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Energy Intake; Fluoxetine; Fructose; GABA-B Receptor Agonists; Habituation, Psychophysiologic; Male; Mice; Mice, Inbred C57BL; Selective Serotonin Reuptake Inhibitors; Topiramate

2010
FPIN’s clinical inquiries. Medications for weight loss in patients with type 2 diabetes mellitus.
    American family physician, 2012, Mar-15, Volume: 85, Issue:6

    Topics: Anti-Obesity Agents; Cyclobutanes; Diabetes Mellitus, Type 2; Fluoxetine; Fructose; Humans; Lactones; Orlistat; Selective Serotonin Reuptake Inhibitors; Topiramate

2012
Fluoxetine, topiramate, and combination of both to stabilize eating behavior before bariatric surgery.
    Actas espanolas de psiquiatria, 2016, Volume: 44, Issue:3

    Topics: Adult; Anti-Obesity Agents; Bariatric Surgery; Drug Therapy, Combination; Feeding Behavior; Female; Fluoxetine; Fructose; Humans; Male; Obesity, Morbid; Preoperative Care; Selective Serotonin Reuptake Inhibitors; Topiramate

2016